Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Mar;46(2):274-283.
doi: 10.1080/21691401.2017.1307210. Epub 2017 Apr 19.

Advances in siRNA Delivery in Cancer Therapy


Advances in siRNA Delivery in Cancer Therapy

Aishwarya Singh et al. Artif Cells Nanomed Biotechnol. .


RNA interference (RNAi)-based therapeutic approaches are under vibrant scrutinisation to seek cancer cure. siRNA suppress expression of the carcinogenic genes by targeting the mRNA expression. However, in vivo systemic siRNA therapy is hampered by the barriers such as poor cellular uptake, instability under physiological conditions, off-target effects and possible immunogenicity. To overcome these challenges, systemic siRNA therapy warrants the development of clinically suitable, safe, and effective drug delivery systems. Herein, we review the barriers, potential siRNA drug delivery systems, and application of siRNA in clinical trials for cancer therapy. Further research is required to harness the full potential of siRNA as a cancer therapeutic.

Keywords: Cancer therapy; RNA interference; biological barriers; gene silencing; siRNA.

Similar articles

See all similar articles

Cited by 19 articles

See all "Cited by" articles


LinkOut - more resources